AVXL — Anavex Life Sciences Share News
0.000.00%
Last trade - 00:00- $106.60m
- -$11.72m
Anavex Life Sciences Corp reports results for the quarter ended in June - Earnings Summary
Brief: Anavex Life Sciences Reports Fiscal 2023 Third Quarter Financial Results
Anavex Life Sciences Corp expected to post a loss of 17 cents a share - Earnings Preview
Brief: Anavex Life Sciences And Partex Group Announce Strategic Partnership
Brief: Anavex®2-73 (Blarcamesine) Receives Compassionate Use Authorization For Pediatric Patients With Rett Syndrome
U.S. STOCKS ON THE MOVE-Cenovus Energy, Compass Pathways,
U.S. STOCKS ON THE MOVE-NovoCure, Intuit, Splash Beverage
U.S. STOCKS ON THE MOVE-TScan Therapeutics, Palantir, Coinbase Global
Anavex up as co completes patient dosing in Rett syndrome drug trial
Brief: Anavex Life Sciences Announces Completion Of Anavex(®)2-73 (Blarcamesine) Excellence Phase 2/3 Rett Syndrome Clinical Trial
Brief: Anavex Announces Issuance Of New U.S. Intellectual Property Compositions Patent For Anavex®2-73 (Blarcamesine)
Anavex Life Sciences Corp reports results for the quarter ended in March - Earnings Summary
Brief: Anavex Life Sciences Reports Fiscal 2023 Second Quarter Financial Results
Anavex Life Sciences Corp expected to post a loss of 19 cents a share - Earnings Preview
Brief: Anavex Life Sciences Announces Issuance Of New U.S. Patent Expanding Anavex®2-73 Blarcamesine Intellectual Property Portfolio For Treatment Of Hypertension
Anavex Life Sciences PT raised by brokerage on drug's success in Parkinson's trial
U.S. STOCKS ON THE MOVE-Piedmont Lithium, Walmart, Kilroy Realty
U.S. STOCKS ON THE MOVE-Walmart, JD.Com, Crinetics
U.S. STOCKS ON THE MOVE-Neogen Corp, Freight Technologies, Philip Morris